Showing results (91-100 of 629) with videos related to
Sort By:
Pageof 63
Nature Reviews. Cardiology|August 5, 2016
Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular diseaseDavide Capodanno, Mark Alberts, Dominick J AngiolilloTherapeutic Advances in Cardiovascular Disease|December 10, 2019
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stentingSergio Buccheri, Dominick J Angiolillo, Davide CapodannoJournal of Thrombosis and Thrombolysis|August 18, 2014
Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonistsFrancesco Franchi, Jafri Syed Hammad, Fabiana Rollini, et al.Circulation|August 26, 2016
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 StudyFrancesco Franchi, Fabiana Rollini, Niti Aggarwal, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|March 4, 2010
Basic principles of platelet biology and clinical implicationsDominick J Angiolillo, Masafumi Ueno, Shinya GotoEuropean Neurology|October 1, 2008
Hypertriglyceridemia and ischemic strokeNader Antonios, Dominick J Angiolillo, Scott SillimanInterventional Cardiology Clinics|August 26, 2019
Pharmacodynamics During Transition Between Platelet P2Y12 Inhibiting TherapiesPiera Capranzano, Bruno Francaviglia, Dominick J AngiolilloExpert Review of Cardiovascular Therapy|July 15, 2020
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitusDario Calderone, Davide Capodanno, Dominick J AngiolilloExpert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J AngiolilloExpert Opinion on Drug Metabolism & Toxicology|October 18, 2023
Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administrationMarco Spagnolo, Dominick J Angiolillo, Davide CapodannoPageof 63